David Cragg - Jun 1, 2021 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role: Chief HR & Admin Officer
Signature: David W. Cragg
Stock symbol: CYTK
Transactions as of: Jun 1, 2021
Transactions value $: -$229,896
Form type: 4
Date filed: 6/2/2021, 04:45 PM
Next filing: Jul 2, 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTK	Common Stock	Options Exercise	$41.3K	+6.56K	+4.07%	$6.30^*	168K	Jun 1, 2021	Direct	F1, F2
transaction	CYTK	Common Stock	Sale	-$142K	-6.56K	-3.91%	$21.63	161K	Jun 1, 2021	Direct	F1, F2
transaction	CYTK	Common Stock	Options Exercise	$53.2K	+8.44K	+5.23%	$6.30^*	170K	Jun 1, 2021	Direct	F1, F2
transaction	CYTK	Common Stock	Sale	-$182K	-8.44K	-4.97%	$21.63	161K	Jun 1, 2021	Direct	F1, F2

Showing 1 to 4 of 4 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYTK	Incentive Stock Option (right to buy)	Options Exercise	$0	-8.44K	-100%	$0.00^*	0	Jun 1, 2021	Common Stock	8.44K	$6.30	Direct	F1
transaction	CYTK	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-6.56K	-100%	$0.00^*	0	Jun 1, 2021	Common Stock	6.56K	$6.30	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2021.
F2	Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.